KANG, Kwi Man,PARK, Young Joon,PARK, Jun Hong,LEE, Ji Eun,YOON, Seok Kee,KIM, Yu Jeong,OH, Tack Oon,CHO, Tae Keun
申请号：
EP14828739
公开号：
EP3025708A4
申请日:
2014.07.25
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor for treating dyslipidemia. The present invention provides a combination formulation and a method for preparing the combination formulation, wherein the combination formulation contains metformin and an HMG-CoA reductase inhibitor, and has effectively improved stability by blocking physical and chemical reactions between the active ingredients while securing the stable release of respective active ingredients.
